IMMUNITYBIO, INC. Gain (Loss) on Disposition of Assets
IMMUNITYBIO, INC. (IBRX) reported Gain (Loss) on Disposition of Assets of -$4.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-03-04
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for the quarter ending 2019-03-31 was $0.00.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for the quarter ending 2018-12-31 was -$75.00K.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for the quarter ending 2018-09-30 was -$44.00K.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for the quarter ending 2018-06-30 was -$54.00K.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for fiscal 2020 was -$4.00K.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for fiscal 2019 was $0.00.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for fiscal 2018 was -$209.00K.
- IMMUNITYBIO, INC. gain (loss) on disposition of assets for fiscal 2017 was -$64.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$4.00K 10-K · filed 2021-03-04 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 | |||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-08 | -$75.00K derived: sum of 2 quarters · filed 2021-03-04 | -$119.00K derived: sum of 3 quarters · filed 2021-03-04 | -$173.00K derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$119.00K derived: sum of 2 quarters · filed 2021-03-04 | -$173.00K derived: sum of 3 quarters · filed 2021-03-04 | -$209.00K 10-K · filed 2021-03-04 |
| 2018-09-30 | -$44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$98.00K derived: sum of 2 quarters · filed 2018-11-07 | -$134.00K 10-Q · filed 2018-11-07 | -$134.00K derived: sum of 4 quarters · filed 2020-03-25 |
| 2018-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$90.00K 10-Q · filed 2018-08-06 | -$90.00K derived: sum of 3 quarters · filed 2020-03-25 | -$154.00K derived: sum of 4 quarters · filed 2020-03-25 |
| 2018-03-31 | -$36.00K 10-Q · filed 2019-05-08 | -$36.00K derived: sum of 2 quarters · filed 2020-03-25 | -$100.00K derived: sum of 3 quarters · filed 2020-03-25 | -$100.00K derived: sum of 4 quarters · filed 2020-03-25 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$64.00K derived: sum of 2 quarters · filed 2020-03-25 | -$64.00K derived: sum of 3 quarters · filed 2020-03-25 | -$64.00K 10-K · filed 2020-03-25 |
| 2017-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$64.00K derived: sum of 2 quarters · filed 2018-11-07 | -$64.00K 10-Q · filed 2018-11-07 | -$64.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $0.00 10-Q · filed 2018-08-06 | $0.00 derived: sum of 3 quarters · filed 2019-03-13 | $0.00 derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | $0.00 derived: sum of 3 quarters · filed 2019-03-13 | -$3.00K derived: sum of 4 quarters · filed 2019-03-13 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $0.00 derived: sum of 2 quarters · filed 2019-03-13 | -$3.00K derived: sum of 3 quarters · filed 2019-03-13 | -$18.00K 10-K · filed 2019-03-13 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$3.00K derived: sum of 2 quarters · filed 2017-11-07 | -$18.00K 10-Q · filed 2017-11-07 | -$18.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$18.00K 10-Q · filed 2017-08-07 | -$18.00K derived: sum of 3 quarters · filed 2018-03-12 | |
| 2016-03-31 | -$15.00K 10-Q · filed 2017-05-08 | -$15.00K derived: sum of 2 quarters · filed 2018-03-12 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $0.00 10-K · filed 2018-03-12 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |